StonvexLoading…
StonvexStonvexStonvexCore line items from ARX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $273.30M | $912.90M | $664.50M | $397.10M |
Operating Income | $2.00M | $-1.32B | $-1.32B | $37.80M |
Net Income | $-4.10M | $-1.35B | $-1.35B | $15.30M |
EPS (Diluted) | $-0.02 | $-7.49 | $-7.93 | $0.07 |
Total Assets | $8.60B | $8.26B | $7.86B | $7.50B |
Total Liabilities | $7.88B | $7.54B | $7.16B | $7.01B |
Cash & Equivalents | $1.45B | $1.72B | $1.60B | $1.39B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 221.98M | 190.26M | 179.62M | 166.19M |